Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 2623 record(s)

Req # A-2021-000595

Documents that address Health Canada protocols for interception or seizure of peyote / mescaline, including, but not limited to, agency protocols for: training related to the seizure of peyote / mescaline, search, notification, testing, storage, destruction, return or forfeiture. Timeline: July 1 2018 to July 15 2021.

Organization: Health Canada

299 page(s)
December 2021

Req # A-2020-001663

Adverse Drug Reactions (ADRs). Report numbers: E2B_02487053, E2B_00963012, E2B_03010075, E2B_03018270, E2B_00379283, E2B_02895814, E2B_03146265, E2B_02946105, E2B_01921167, E2B_00026099, E2B_03074645, E2B_02949926, E2B_01693832, E2B_01429317, E2B_03224675.

Organization: Health Canada

752 page(s)
December 2021

Req # A-2016-001556

All briefing materials provided to the Minister of Health regarding Apotex Inc., AA Pharma, and/or the drug Mefloquine also known under the brand name Lariam from November 1, 2015 and January 13, 2017.

Organization: Health Canada

56 page(s)
December 2021

Req # A-2017-000961

All records, including but not limited to messages both internal and external from Health Canada related to Wapekeka First Nation from December 2016 -February 2017, and then April - May, 2017. Exclude drafts, media lines, media monitoring and any other media related materials and publicly available documents.

Organization: Health Canada

863 page(s)
December 2021

Req # A-2017-000969

All records sent to and from Valerie Gideon regarding Cross Lake First Nation, also known as Pimicikamak, from July 4, 2016 until Oct. 16, 2017. Exclude publicly available information and media articles and media lines. Please include media monitoring and media inquiries. Only provide the most recent version of each record.

Organization: Health Canada

104 page(s)
December 2021

Req # A-2017-001404

All 2017 correspondence between food industry stakeholders and Health Canada related to the revision of Canada's food guide.

Organization: Health Canada

798 page(s)
December 2021

Req # A-2018-001921

All records relating to correspondence, including the actual correspondence, between Quebec Minister of Health and Social Services Danielle McCann and/or Minister of Economy and Innovation Pierre Fitzgibbon to federal Minister of Health Ginette Petitpas Taylor between October 1, 2018 and March 26, 2019.

Organization: Health Canada

17 page(s)
December 2021

Req # A-2019-000218

All records related to Stelpro Design and Uniwatt construction heaters recalled due to a fire risk, from 2000 to May 13, 2019.

Organization: Health Canada

283 page(s)
December 2021

Req # A-2019-001018

All public and internal records of any kind created by the Water and Air Quality Bureau, Safe Environments Directorate, Healthy Environments and Consumer Safety Branch, Health Canada about the study published in JAMA Pediatrics in August 2019, entitled "Association Between Maternal Fluoride Exposure During Fetal Development and IQ Scores in Offspring in Canada.

Organization: Health Canada

120 page(s)
December 2021

Req # A-2019-001019

All public and internal records created by Health Canada (excluding the Water and Air Quality Bureau) about the study published in JAMA Pediatrics in August 2019, entitled "Association Between Maternal Fluoride Exposure During Fetal Development and IQ Scores in Offspring in Canada.

Organization: Health Canada

198 page(s)
December 2021
Date modified: